Index BRCA1/2 testing under a multidisciplinary program von Machado, D.H.R., Fragoso, S., Opinião, A., Clara, A., Bento, S., Luís, A.C., Miguel, I., Santos, S., Machado, P., Rodrigues, P., Parreira, J., Vaz, F.

Volltext

Individual and familial phenotype in hereditary ovarian cancer von Mira, M.B.D.O., Miguel, I., Fragoso, S., Opinião, A., Luís, A.C., Clara, A., Bento, S., Machado, P., Santos, S., Rodrigues, P., Parreira, J., Vaz, F.

Volltext

2721 Gestational Trophoblastic Neoplasia - a 10-year experience of a cancer centre von Nunes, H, Vaz, F, Opinião, A, Guimarães, A, Felix, A, Francisc, A, Moreira, A

Volltext

1906 Management of BRCA 1/2 mutation carriers: 14 years of a multidisciplinary program von Rocha, G, Luís, A, Clara, A, Opinião, A, Bento, S, Dupont, J, Rodrigues, P, Simões, C, Parreira, J, Fragoso, S, Santos, S, Machado, P, Moura, M, Rocha, M, Faria, L, Marques, J.C, Moura, C, Silva, J, Vaz, F

Volltext

P125 Breast carcinoma in situ in women with BRCA1 and BRCA2 mutations: a single institution review von Cardoso, C.C, Luís, A, Machado, P, Clara, A, Opinião, A, Bento, S, Faria, J.L, Marques, J.C, Santos, S, Vaz, F

Volltext

766P Mapping BRCA1/2 variants in ovarian cancer patients: Contribution of a BRCA2 founder effect von Duarte, T., Fragoso, S., Antunes Meireles, P., Oliveira, I.C., Rodrigues, P., Bexiga, C., Mira, B., Opinião, A., Luís, A.C., Miguel, I., Bento, S., Vaz, F., Santos, S.

Volltext

770P Wild-type BRCA1/2 ovarian cancer: Prospective follow-up data from a multidisciplinary program von Oliveira, I.C., Antunes Meireles, P., Pereira, C., Rodrigues, P., Duarte, T., Santos, S., Mira, B., Opinião, A., Luís, A.C., Miguel, I., Fragoso, S., Vaz, F.

Volltext

765P Prognosis of BRCA1 and BRCA2 ovarian cancer: Prospective follow-up data from a multidisciplinary program von Antunes Meireles, P., Oliveira, I.C., Rodrigues, P., Duarte, T., Santos, S., Mira, B., Bexiga, C., Pereira, C., Opinião, A., Luís, A.C., Miguel, I., Fragoso, S., Vaz, F.

Volltext

2009P - Non-BRCA1/2 hereditary breast and ovarian cancer: Findings from a multidisciplinary program von Monteiro, A., Machado, P., Clara, A.I., Opinião, A., Luis, A., Miguel, I., Louro, P., Santos, S., Fragoso, S., Rodrigues, P., Rodrigues, F., Coelho, I., Parreira, J., Vaz, F.

Volltext

Non-BRCA1/2 hereditary breast and ovarian cancer: Findings from a multidisciplinary program von Monteiro, A., Machado, P., Clara, A.I., Opinião, A., Luis, A., Miguel, I., Louro, P., Santos, S., Fragoso, S., Rodrigues, P., Rodrigues, F., Coelho, I., Parreira, J., Vaz, F.

Volltext

Abstract P5-09-09: CHEK2: the third susceptibility BReast CAncer (BC) gene? von Gomes, VL, Machado, P, Fragoso, S, Santos, S, Coelho, I, Parreira, J, Rodrigues, P, Rodrigues, F, Clara, A, Bento, S, Luís, A, Opinião, A, Vaz, F

Volltext

237PIndex BRCA1/2 testing under a multidisciplinary program von Machado, D H R, Fragoso, S, Opinião, A, Clara, A, Bento, S, Luís, A C, Miguel, I, Santos, S, Machado, P, Rodrigues, P, Parreira, J, Vaz, F

Volltext

993PIndividual and familial phenotype in hereditary ovarian cancer von Mira, M B D O, Miguel, I, Fragoso, S, Opinião, A, Luís, A C, Clara, A, Bento, S, Machado, P, Santos, S, Rodrigues, P, Parreira, J, Vaz, F

Volltext

2009PNon-BRCA1/2 hereditary breast and ovarian cancer: Findings from a multidisciplinary program von Monteiro, A, Machado, P, Clara, A I, Opinião, A, Luis, A, Miguel, I, Louro, P, Santos, S, Fragoso, S, Rodrigues, P, Rodrigues, F, Coelho, I, Parreira, J, Vaz, F

Volltext

Does melanoma or other skin cancers belong to the BRCA2 phenotype? von Vitorino, R., Vaz, F., Carvalho, A.L., Bento, S., Luís, A., Opinião, A., Clara, A., Dupont, J., Santos, S., Machado, P., Fragoso, S., Rodrigues, P., Parreira, J., Moura, C.

Volltext

Primary Cytoreductive Surgery (Pcs) Vs Neoadjuvant Chemotherapy (Nact) for Advanced Ovarian Carcinoma (Aoc): Decision Criteria and Efficacy Outcomes von Nunes, H., Vaz, F., Mayer, A., Jorge, A.F., Margarida, T., Opinião, A., Guimarães, A., Moreira, A.

Volltext

898PPRIMARY CYTOREDUCTIVE SURGERY (PCS) VS NEOADJUVANT CHEMOTHERAPY (NACT) FOR ADVANCED OVARIAN CARCINOMA (AOC): DECISION CRITERIA AND EFFICACY OUTCOMES von Nunes, H., Vaz, F., Mayer, A., Jorge, A.F., Margarida, T., Opinião, A., Guimarães, A., Moreira, A.

Volltext

1314 Review of cancer diagnoses in BRCA 1/2 carriers: hypersensitivity of BRCA 1/2 patients to cisplatin may also aply to uterine carcinosarcoma (UCS) von Silva, I, Vaz, F, Francisca, A, Fonseca, I, Rodrigues, P, Opinião, A, Machado, P, Oliveira, J

Volltext

5044 POSTER Quality of life in cervical cancer survivors treated with chemoradiotherapy von Assensio, N, Opinião, A, Roldão, M, Diniz, M, Oliveira, J, Vaz, F

Volltext

512PD - Portuguese High-Risk Breast/Ovarian Cancer: Survival Analysis von Machado, P., Clara, A., Mayer, A., Fragoso, S., Santos, S., Luís, A., Opinião, A., Parreira, J., Simões, C., Vaz, F.

Volltext